APOC3 and diabetic kidney disease: Huan et al. 75 found that ApoC3 exacerbates renal inflammation through activation of the TLR2/NF-κB pathway, leading to the initial development of DKD, and that this effect is independent of the triglyceride-regulating effects of ApoC3.